F 0552
Ensure that residents are fully informed and understand their health status, care and treatments.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to inform the conservator (an individual appointed by a court
to oversee the mental health care of an individual with a serious mental illness who is unable to make
decisions themselves) of the risks and benefits of proposed care, of treatment and treatment alternatives or
treatment options and to choose the alternative or option he or she prefers in advance of a medication
change for one of two sampled residents (Resident 1). Resident 1 was receiving Clozapine (medication
used to treat severely ill patients with Schizophrenia who have used other medicines that did not work well)
for her diagnosed Schizophrenia (a chronic mental health disorder characterized by a disconnection from
reality) prior to her admission to the facility and upon admission to the facility on 7/22/2024, and it was
placed on hold for an unknown reason from 8/3/2024 until discharge from facility on 10/25/2024, without
conservator knowledge.
Residents Affected - Few
This deficient practice caused a decline in Resident 1's mental health status and resulted in a hospital
readmission for treatment of her Schizophrenia.
Findings:
A review of a facility policy titled, Resident Representative, with a revised date of February 2021, indicated,
The facility treats the decisions of the resident representative as the decisions of the resident . to the extent
required by the court . If the resident is determined to be incompetent . the rights of the resident will devolve
to and will be exercised by the resident representative appointed to act on the resident ' s behalf. This
document indicated that a resident representative can be defined as a court-appointed guardian or
conservator of the resident. The facility will treat the decisions of a resident representative as the decisions
of the resident .
A review of a facility policy titled, Use of Psychotropic Medication(s), with no revised date, indicated, The
indications for initiating, maintaining, or discontinuing medication(s) . will be determined by evaluating the
resident . including the assessment of relative benefits and risks, and the preferences and goals for
treatment. This document further indicated, The resident ' s medical record shall include documentation of
this evaluation and the rationale for chosen treatment options. This includes any indicated documentation of
rationale for prescribing multiple psychotropic medications or switching from one type of psychotropic
medication . Prior to initiating or increasing a psychotropic medication, the resident, family, and/or resident
representative must be informed of the benefits, risks, and alternatives for the medication . in advance of
such initiation or increase. The facility will document that the resident or resident representative was
informed in advance of the risks and benefits of the proposed care . and the preferred option to accept or
decline .
A review of the facility ' s records indicated Resident 1 was admitted to the facility on [DATE]
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
055612
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055612
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Feather River Care Center
1 Gilmore Lane
Oroville, CA 95966
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0552
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
and discharged to the acute care hospital on [DATE]. Resident 1 had diagnoses that included
Schizophrenia, dysphagia (difficulty swallowing) and sepsis (life threatening medical emergency when a
body ' s response to an infection harms its own tissues and organs). Resident 1 had a conservator contact
on file indicated as their Responsible Party to make decisions.
A review of a document titled, Informed consent, indicated that Resident 1 had signed an informed consent
form on 9/3/2024 for Paliperidone 1.5 mg daily (an antipsychotic medication used to help treat
schizophrenia). This form was signed by a licensed staff member and the Medical Physician; however, it
was not signed by the resident ' s responsible party.
A review of the facility ' s progress note dated 10/18/2024 at 1:01 PM by Licensed Vocational Nurse (LVN1),
indicated, Nursing observations, evaluation, and recommendation are: on 10/18/24. After reviewing
medications, it was determined that resident should be taking Clozapine, MD (Medical Physician) made
aware due to unable to be prescribed by MD he gave new order to transfer to acute. RP aware.
A review of the facility ' s Medication Administration Record (MAR), indicated that Clozapine Oral Tablet 100
mg for Schizophrenia had a start date at the facility for 7/22/2024, a hold date on 8/3/2024 and an eventual
discontinuation date on 10/4/2024. Paliperidone Extended Release Oral Tablet 1.5 mg for Schizophrenia
had a start date on 7/23/2024 until Resident 1 discharged from the facility.
During an interview on 5/14/2025 at 4:50 PM with Behavioral Health (BH1), stated, Resident 1 had to get
hospitalized due to psychiatric medications being changed without her conservator ' s permission, causing
deterioration in her health. BH1 further stated that Resident 1 was on a [NAME]-Petris-Short (LPS)
Conservatorship (a legal arrangement where a court appoints a conservator to be responsible for the
comprehensive medical treatment of an adult who has a serious mental illness and is deemed gravely
disabled. The appointed conservator has the legal authority to make decisions regarding the resident ' s
mental health treatment, including consenting to medication. The conservator has the authority to ensure
they receive mandatory medication).
During an interview on 5/28/2025 at 9:24 AM with LVN1, stated Resident 1 did need the medication
Clozapine and since the medical physician was unable to prescribe it, Resident 1 was transferred to acute
care. LVN1 stated he was unsure of why the physician could not prescribe the medication.
During an interview on 5/28/2025 at 9:40 AM with BH2, stated Resident 1 was LPS conserved which meant
that medication can be forced if need be in an appropriate manner. BH2 stated that the facility changed
Resident 1 ' s medication without consent from the conservator and discontinued her medication without
the conservator ' s knowledge, and they should have been contacted. They didn ' t notify us they changed
her medication. We don ' t know why they put the medication on hold, you can ' t just stop that medication
they completely decompensate. She just got worse and worse. BH2 stated the conservator was never
consulted until Resident 1 was already decompensated, and she had been on these medications for a long
period of time given that she had been under a conservatorship for about 20 years. I think they didn ' t
follow protocol. Maybe they felt they got consent from her, but they needed it from the conservator who
should have been called and informed each time Resident 1 had refused medications. BH2 stated the
conservator must consent to medication changes; however, no consent was given to the doctor to pull
Resident 1 off of her medications or change her medications. They need to have a consequence for doing
this, so they don ' t do it again.
During an interview on 5/28/2025 at 10:37 AM with Administrator, stated, there is only an informed consent
form for Paliperidone and not one for Clozapine for Resident 1.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055612
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055612
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Feather River Care Center
1 Gilmore Lane
Oroville, CA 95966
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0552
During an interview on 6/4/2025 at 3:57 PM with Administrator, confirmed that there was no further
documentation that would have indicated why Resident 1 ' s Clozapine was held by the Medical Physician.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055612
If continuation sheet
Page 3 of 3